Since DOC2A has been reported as a suppressor gene in many carcinomas such as colorectal cancer and urothelial cancer [34, 35], we suggest AHR might promote glioma progression through inhibiting the tumor suppressor gene, DOC2A. This evidence concerns the gene DOC2A and glioma.